학술논문

Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial
Document Type
Article
Author
Dolan, MonicaYeh, ErlindaSheth, KevinKunze, KimberlyMuehlschlegel, SusanneNieto, IrynaClaassen, JanFalo, CristinaHuang, DavidBeckwith, AnneMesse, StevenYates, MelissaO'Phelan, KristineEscobar, AndreaBecker, KyraTanzi, PatriciaGonzales, NicoleTremont, ChadVenkatasubramanian, ChitraThiessen, RositaSave, SupriyaVerrault, StevenCollard, KarinDeGeorgia, MichaelCwiklinski, ValerieThompson, BradfordWasilewski, LesleyAndrews, CharlesBurfeind, RobertTorbey, MichelHamed, MohammadButcher, KennethSivakumar, LekaVarelas, NicolaouMays-Wilson, KathleenLeira, EnriqueOlalde, HeenaSilliman, ScottCalhoun, RhondaDangayach, NehaRenvill, RicardoMalhotra, RishiKordesch, KristinaLord, AaronCalahan, ThomasGeocadin, RomergrykoParish, MichelleFrey, JamesHarrigan, MaryLeifer, DanaMathias, RynaSchneck, MichaelBernier, TaraGonzales-Arias, SergioElysee, JosetteLopez, GeorgeVolgi, JosephineBrown, RobertJasak, SaraPhillips, StephenJarrett, JudithGomes, JoaoMcBride, MoneenAldrich, FrancoisAldrich, CharleneKornbluth, JoshuaBettle, MichelleGoldstein, JoshuaTirrell, GregoryShaw, QaisarJonczak, KarinSelim, MagdyFoster, Lydia DMoy, Claudia SXi, GuohuaHill, Michael DMorgenstern, Lewis BGreenberg, Steven MJames, Michael LSingh, VineetaClark, Wayne MNorton, CaseyPalesch, Yuko YYeatts, Sharon D
Source
In The Lancet Neurology May 2019 18(5):428-438
Subject
Primary Research
Articles
Language
ISSN
1474-4422